Proprietary Pipeline

A key element in our strategy is to advance our proprietary pipeline.

Advancing our proprietary pipeline

Our breast cancer vaccine is the most advanced proprietary program, and has demonstrates promising preclinical results. Additionally, ExpreS2ion collaborates with Evaxion A/S on a cytomegalovirus vaccine, utilising a proprietary AI-driven technology platform. We also explore several undisclosed assets with shorter timelines and cost-effective paths to value creation.